The clinical demand for steroid drug is increasing fast due to its wide application and good efficacy especially its extended use in regulating human endocrine and slowing down ageing in recent years.
Progesterone, a natural progestogen produced by the corpus luteum, has significant morphological effects on endometrium stimulated by estrogen and is essential to supporting pregnancy. It is used for the reactive diagnosis of amenorrhea caused by threatened abortion and habitual abortion or the reasons for amenorrhea.
According to CRI’s market survey, progesterone develops fast after entering China with annual sales value rising from less than CNY 2 million in 2005 to CNY 137 million in 2014 and CAGR during this period reaching up to 60.8%. Part of progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd, Guangzhou Baiyun Shan Ming Xing Pharmaceutical Co., Ltd. Fleet (UK) has the largest market share of about 31% in 2014for sales value while Xianju Pharmaceutical takes up the biggest share of about 59% for sales volume.
It is estimated that with the advances in medical technology and improvements in healthcare, the clinical demand for steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone in the Chinese market will further grow.
Readers can get at least the following information from this report:
-market size of progesterone in China
-competitive landscape of progesterone in Chinese market
-price of progesterone made by different manufacturers in China
-market outlook of progesterone in China
The author suggests the following groups of people purchase this report:
-manufacturers of progestational hormone
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service